2019
DOI: 10.1007/s11011-019-00498-x
|View full text |Cite
|
Sign up to set email alerts
|

Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury – A potential therapeutic agent for Alzheimer’s Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(19 citation statements)
references
References 75 publications
3
16
0
Order By: Relevance
“…Results of this study revealed that the administration of scopolamine reduced percentage alternation in Y‐maze, and increased escape latency in MWM tasks. This result supports previous studies that scopolamine induces cognitive impairment in animals (Hashimoto, Hatayama, Nakamichi, & Yoshida, 2014; Klinkenberg & Blokland, 2010; Kwon, Kim, Lee, & Jang, 2009; Ponne, Kumar, & Boopathy, 2020). However, pretreatment with A. paniculata extract and donepezil reversed the increase in escape latency and a decline in memory function caused by scopolamine administration.…”
Section: Discussionsupporting
confidence: 92%
“…Results of this study revealed that the administration of scopolamine reduced percentage alternation in Y‐maze, and increased escape latency in MWM tasks. This result supports previous studies that scopolamine induces cognitive impairment in animals (Hashimoto, Hatayama, Nakamichi, & Yoshida, 2014; Klinkenberg & Blokland, 2010; Kwon, Kim, Lee, & Jang, 2009; Ponne, Kumar, & Boopathy, 2020). However, pretreatment with A. paniculata extract and donepezil reversed the increase in escape latency and a decline in memory function caused by scopolamine administration.…”
Section: Discussionsupporting
confidence: 92%
“…Oxidative stress has also been proposed as the possible cause of neurocognitive disease along with the cholinergic hypothesis. Regarding the use of scopolamine, previous studies have reported the association of systemic administration of scopolamine with increased oxidative stress in the brain, especially the areas associated with memory and learning, such as the hippocampus and prefrontal cortex, some of which are reported to be involved in mitochondrial dysfunction 15,32 . Furthermore, scopolamine-induced memory impairment is successfully attenuated by several anti-oxidant compounds, emphasizing the crucial role of oxidative stress in scopolamine-induced amnesia 14,33 .…”
Section: Discussionmentioning
confidence: 99%
“…Oxidative stress has also been proposed as the possible cause of neurocognitive disease along with the cholinergic hypothesis. Regarding the use of scopolamine, previous studies have reported the association of systemic administration of scopolamine with increased oxidative stress in the brain, especially the areas associated with memory and learning, such as the hippocampus and prefrontal cortex, some of which are reported to be involved in mitochondrial dysfunction (16,37,38). Furthermore, scopolamine-induced memory impairment is successfully attenuated by several anti-oxidant compounds, emphasising the crucial role of oxidative stress in scopolamine-induced amnesia (39,40).…”
Section: Discussionmentioning
confidence: 99%